Impact of parallel micro-engineered stent grooves on endothelial cell migration, proliferation, and function: An in vivo correlation study of the healing response in the coronary swine model

Circulation: Cardiovascular Interventions

Volumn 5, Issue 4, 2012, Pages 499-507

  Sprague, Eugene A ^a   Tio, Fermin ^a   Ahmed, S Hinan ^a   Granada, Juan F ^b   Bailey, Steven R ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Coronary stent; Endothelial function; Endothelialization; Neointimal hyperplasia; Restenosis

Indexed keywords

NITRIC OXIDE; STAINLESS STEEL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; CORRELATIONAL STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IN-STENT RESTENOSIS; MICROTECHNOLOGY; NEOINTIMA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TREATMENT RESPONSE;

ANIMALS; AORTA; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMIUM ALLOYS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; NEOINTIMA; PROSTHESIS DESIGN; STAINLESS STEEL; STENTS; SUS SCROFA; WOUND HEALING;

EID: 84867849008     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.967901     Document Type: Article

References (35)

1. Stone GW, Ellis SG, Colombo A, Grube E, Popma JJ, Uchida T, Bleuit JS, Dawkins KD, Russell ME. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the taxus clinical trial program. J Am Coll Cardiol Cardiovasc Interv. 2011;4:530-542.
2. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202.
3. Granada JF, Alviar CL, Wallace-Bradley D, Osteen M, Dave B, Tellez A, Win HK, Kleiman NS, Kaluza GL, Lev EI. Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. J Thromb Thrombolysis. 2010;29:60-69.
4. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166-170.
5. Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol. 2010;56:S43-S78.
6. Lemesle G, Maluenda G, Collins SD, Waksman R. Drug-eluting stents: issues of late stent thrombosis. Cardiol Clin. 2010;28:97-105.
7. Co M, Tay E, Lee CH, Poh KK, Low A, Lim J, Lim IH, Lim YT, Tan HC. Use of endothelial progenitor cell capture stent (genous bio-engineered r stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J. 2008;155:128-132.
8. Palmaz JC, Benson A, Sprague EA. Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol. 1999;10:439-444.
9. Bailey SR, Fuss C, Palmaz JC, Sprague EA. Surface micro grooves (MG) improve endothelialization rate in vitro and in vivo. J Am Coll Cardiol. 2001;37:70A.
10. Sprague EA, Luo J, Palmaz JC. Human aortic endothelial cell migration onto stent surfaces under static and flow conditions. J Vasc Intervent Radiol. 1997;8:83-92.
11. Aravindan N, Mohan S, Herman TS, Natarajan M. Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis. J Cell Biochem. 2009;106:999-1009.
12. Hamuro M, Polan J, Natarajan M, Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis. 2002;162:277-287.
13. Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, Waksman R, Weinberger J, Wilensky RL, Jensen DN, Zuckerman BD, Virmani R. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002;106:1867-1873.
14. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011;58:1569-1577.
15. Chehroudi B, McDonnell D, Brunette DM. The effects of micromachined surfaces on formation of bonelike tissue on subcutaneous implants as assessed by radiography and computer image processing. J Biomed Mater Res. 1997;34:279-290.
16. Frenkel SR, Simon J, Alexander H, Dennis M, Ricci JL. Osseointegration on metallic implant surfaces: effects of microgeometry and growth factor treatment. J Biomed Mater Res. 2002;63:706-713.
17. Dibra A, Kastrati A, Mehilli J, Pache J, von Oepen R, Dirschinger J, Schomig A. Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial. Catheter Cardiovasc Interv. 2005;65:374-380.
18. Bhadriraju K, Yang M, Alom Ruiz S, Pirone D, Tan J, Chen CS. Activation of rock by rhoa is regulated by cell adhesion, shape, and cytoskeletal tension. Exp Cell Res. 2007;313:3616-3623.
19. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science. 1997;276:1425-1428.
20. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog. 1998;14:356-363.
21. Amezcua JL, Dusting GJ, Palmer RM, Moncada S. Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br J Pharmacol. 1988;95:830-834.
22. Colotti C, Vittorini S, Ottaviano V, Maltinti M, Angeli V, Del Ry S, Giannessi D. Nitric oxide treatment reduces neo-intimal formation and modulates osteopontin expression in an ex-vivo human model of intimal hyperplasia. Cytokine. 2009;46:228-235.
23. Fischer JW, Hawkins S, Clowes AW. Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. J Vasc Surg. 2004;40:115-122.
24. Garanich JS, Pahakis M, Tarbell JM. Shear stress inhibits smooth muscle cell migration via nitric oxide-mediated downregulation of matrix metalloproteinase-2 activity. Am J Physiol Heart Circ Physiol. 2005;288:H2244-H2252.
25. Groves PH, Banning AP, Penny WJ, Newby AC, Cheadle HA, Lewis MJ. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res. 1995;30:87-96.
26. Kaul S, Cercek B, Rengstrom J, Xu XP, Molloy MD, Dimayuga P, Parikh AK, Fishbein MC, Nilsson J, Rajavashisth TB, Shah PK. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB. J Am Coll Cardiol. 2000;35:493-501.
27. Kibbe MR, Tzeng E, Gleixner SL, Watkins SC, Kovesdi I, Lizonova A, Makaroun MS, Billiar TR, Rhee RY. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg. 2001;34:156-165.
28. Allaire E, Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg. 1997;63:582-591.
29. Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, Coleman L, Wong GK, Edelman ER. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation. 2011;123:1400-1409.
30. Clowes AW, Clowes MM, Fingerle J, Reidy MA. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol. 1989;14:S12-S15.
31. Lim WH, Seo WW, Choe W, Kang CK, Park J, Cho HJ, Kyeong S, Hur J, Yang HM, Lee YS, Kim HS. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thromb Vasc Biol. 2011;31:2798-2805.
32. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol. 2005;45:1574-1579.
33. Klomp M, Beijk MA, Varma C, Koolen JJ, Teiger E, Richardt G, Bea F, van Geloven N, Verouden NJ, Chan YK, Woudstra P, Damman P, Tijssen JG, de Winter RJ. One-year outcome of TRIAS HR (Tri-Stent Adjudication Study-High Risk of Restenosis): a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. J Am Coll Cardiol Cardiovasc Interv. 2011;4:896-904.
34. van Beusekom HM, Ertas G, Sorop O, Serruys PW, van der Giessen WJ. The genous endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv. 2011;79:231-242.
35. Granada JF, Inami S, Aboodi MS, Tellez A, Milewski K, Wallace-Bradley D, Parker S, Rowland S, Nakazawa G, Vorpahl M, Kolodgie FD, Kaluza GL, Leon MB, Virmani R. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv. 2010;3:257-266.